1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
56,50,000 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.07 | 71.99 | 50.62 | 44.13 |
| Total Income | 63.71 | 108.19 | 89.61 | 71.72 |
| Profit After Tax | 9.73 | 18.26 | 11.04 | 5.21 |
| EBITDA | 13.39 | 25.76 | 15.73 | 8.12 |
| Reserves and Surplus | 37.11 | 49.86 | 31.60 | 20.57 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹65.51 (+1.93%) |
| Sai Parenteral's Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹535.60 (-0.34%) |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,113.00 (+4.28%) |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,520.20 (-0.78%) |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹163.00 (-0.61%) |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.01 (-0.40%) |
| Bio Medica Laboratories Ltd. | SME | ₹52.43 Cr | ₹139 | 13.03 | ₹115.80 | -16.69% | ₹138.70 (-0.18%) |
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹43 | 10.47 | ₹56.77 | +32.02% | ₹38.13 (-4.65%) |
| Speciality Medicines Ltd. | SME | ₹29.14 Cr | ₹124 | 9.27 | ₹125.90 | +1.53% | ₹185.00 (+0.00%) |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹273.75 (+0.09%) |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹255.30 (+2.51%) |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹112.00 (+1.82%) |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹254.50 (+1.13%) |
About Rodec Pharma IPO
Incorporated in 1997, Rodec Pharma Ltd. is engaged in the manufacturing of animal feed supplements and the marketing of veterinary pharmaceutical drugs and animal feed supplements for the animal healthcare sector. The company operates an integrated business model covering manufacturing, distribution, and marketing, enabling supply of products to end users across multiple regions. Its product portfolio comprises veterinary pharmaceutical drugs and animal feed supplements, with 35 products and 29 variants across categories such as antibiotics, antispasmodics, ectoparasiticides, and nutritional supplements. Rodec Pharma Ltd. has a distribution network spread across several Indian states, including Maharashtra, Haryana, Uttar Pradesh, Punjab, Gujarat, Rajasthan, Assam, Madhya Pradesh, Telangana, Chhattisgarh, Bihar, Jharkhand, Uttarakhand, Himachal Pradesh, and West Bengal. The company employs 602 people.+ Read More
Contact Details
Rodec Pharma Ltd. AddressC-2,Site-3Meerut Road Industrial Area,Ghaziabad, Uttar Pradesh, 201001cs@rodec.inVisit Website